Invention Grant
- Patent Title: Compositions and methods for weight loss in at risk patient populations
-
Application No.: US14635518Application Date: 2015-03-02
-
Publication No.: US09119850B2Publication Date: 2015-09-01
- Inventor: Preston Klassen , Kristin Taylor
- Applicant: Orexigen Therapeutics, Inc.
- Applicant Address: US CA La Jolla
- Assignee: Orexigen Therapeutics, Inc.
- Current Assignee: Orexigen Therapeutics, Inc.
- Current Assignee Address: US CA La Jolla
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61P3/04 ; A61K31/137
Abstract:
The present disclosure relates to compositions, kits, uses, systems and methods related to naltrexone plus bupropion for treating an overweight or obese subject at increased risk of adverse cardiovascular outcomes. Preferably, the subject has had type-two diabetes for a period of less than 6 years or is a current smoker, optionally that does not have type-two diabetes.
Public/Granted literature
- US20150182524A1 COMPOSITIONS AND METHODS FOR WEIGHT LOSS IN AT RISK PATIENT POPULATIONS Public/Granted day:2015-07-02
Information query
IPC分类:
